EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Orthobiologics: Current Evidence and What Lies Beyond the Horizon?

Prableen Kaur Chatha iD, Saavi Reddy Pellakuru, Rajesh Botchu, Rajesh Sasidharan, Amit Thakur, Shashank Chapala, Prashant Sarda, Meemansa Jindal, Gaurav Kant Sharma iD

Seminars in Musculoskeletal Radiology · 2026-02 · 30 (01) · 014-027

DOI: 10.1055/a-2724-9777 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Musculoskeletal Radiology, online erschienen am 20.02.2026. Verfasst von Prableen Kaur Chatha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jaipur Institute of Pain and Sports Injuries (JIPSI), Jaipur, Rajasthan, India. Hauptthemen laut MEDLINE: Musculoskeletal Diseases, Regenerative Medicine, Biological Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orthobiologics, a subset of regenerative medicine, involves autologous or allogeneic cells and bioactive molecules to promote musculoskeletal tissue repair and regeneration. This review examines the evolution, clinical applications, limitations, and future directions of orthobiologic therapies. Modalities such as mesenchymal stromal cells, platelet-rich plasma, extracellular vesicles, and growth factors have shown promise in managing tendinopathy, partial tears of ligaments and tendons, osteoarthritis, avascular necrosis, and other soft tissue injuries. These therapies can modulate inflammation, enhance healing, and potentially delay disease progression. However, clinical translation is hindered by donor variability, lack of preparation and procedural standardization, safety concerns with stem cell use, inconsistent evidence, and the absence of consensus guidelines. The unregulated market has also led to widespread use of unproven biologics. Future integration into core clinical practice requires standardized protocols, regulatory oversight, and robust clinical trials. Advances in gene therapy and endogenous stem cell mobilization may further enhance therapeutic outcomes and position orthobiologics as a key component of joint preservation and regenerative musculoskeletal care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Musculoskeletal DiseasesRegenerative MedicineBiological TherapyHumans

Autor:innen und Institutionen

  • Jaipur Institute of Pain and Sports Injuries (JIPSI), Jaipur, Rajasthan, India.
  • Department of Radiology, Apollo Institute of Medical Sciences and Research, Hyderabad, India.
  • Department of Musculoskeletal Radiology, Royal Orthopaedic Hospital, Birmingham, United Kingdom.
  • Department of Interventional Radiology, Rajagiri Hospital, Kochi, Kerala, India.
  • Department of Radiology, AIG Hospital, Hyderabad, India.
  • Department of Radiodiagnosis, SGRR Medical College and Hospital, Dehradun, Uttarakhand, India.

ORCID-Profile: Prableen Kaur Chatha, Gaurav Kant Sharma

Zitieren

APA

Chatha, P. K., Pellakuru, S. R., Botchu, R., Sasidharan, R., Thakur, A., Chapala, S., Sarda, P., Jindal, M., & Sharma, G. K. (2026). Orthobiologics: Current Evidence and What Lies Beyond the Horizon?. Seminars in Musculoskeletal Radiology, 30(01), 014-027. https://doi.org/10.1055/a-2724-9777

Vancouver

Chatha PK, Pellakuru SR, Botchu R, Sasidharan R, Thakur A, Chapala S, et al. Orthobiologics: Current Evidence and What Lies Beyond the Horizon?. Seminars in Musculoskeletal Radiology. 2026;30(01):014-027. doi:10.1055/a-2724-9777

BibTeX
@article{Chatha2026,
  author = {Chatha, Prableen Kaur and Pellakuru, Saavi Reddy and Botchu, Rajesh and Sasidharan, Rajesh and Thakur, Amit and Chapala, Shashank and Sarda, Prashant and Jindal, Meemansa and Sharma, Gaurav Kant},
  title = {Orthobiologics: Current Evidence and What Lies Beyond the Horizon?},
  journal = {Seminars in Musculoskeletal Radiology},
  year = {2026},
  volume = {30},
  number = {01},
  pages = {014--027},
  doi = {10.1055/a-2724-9777}
}
Kostenlos starten →